{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:20:32Z","timestamp":1783455632239,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"DOI":"10.1007\/s11845-026-04473-1","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:37:08Z","timestamp":1783409828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A predictive nomogram for relapse risk in children with autoimmune encephalitis"],"prefix":"10.1007","author":[{"given":"Wen-ting","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"2","key":"4473_CR1","first-page":"e13307","volume":"13","author":"K Hon","year":"2021","unstructured":"Hon K, Leung AK, Au CC et al (2021) Autoimmune Encephalitis in Children: From Suspicion to Diagnosis[J]. Cureus 13(2):e13307","journal-title":"Cureus"},{"issue":"6","key":"4473_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","volume":"22","author":"J Dalmau","year":"2023","unstructured":"Dalmau J, Graus F (2023) Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease[J]. Lancet Neurol 22(6):529\u2013540","journal-title":"Lancet Neurol"},{"issue":"3","key":"4473_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.25421","volume":"85","author":"JA Lim","year":"2019","unstructured":"Lim JA, Lee ST, Moon J et al (2019) Development of the clinical assessment scale in autoimmune encephalitis[J]. Ann Neurol 85(3):352\u2013358","journal-title":"Ann Neurol"},{"issue":"1","key":"4473_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/10408363.2023.2247482","volume":"61","author":"S Masciocchi","year":"2024","unstructured":"Masciocchi S, Businaro P, Scaranzin S et al (2024) General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis[J]. Crit Rev Clin Lab Sci 61(1):45\u201369","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"8","key":"4473_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2174\/1871527319666200708133103","volume":"19","author":"MS Nissen","year":"2020","unstructured":"Nissen MS, Ryding M, Meyer M et al (2020) Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment[J]. CNS Neurol Disord Drug Targets 19(8):584\u2013598","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"4473_CR6","doi-asserted-by":"publisher","first-page":"e682","DOI":"10.1212\/NXI.0000000000000682","volume":"7","author":"MAAM de Bruijn","year":"2020","unstructured":"de Bruijn MAAM, Bruijstens AL, Bastiaansen AEM et al (2020) Pediatric autoimmune encephalitis: Recognition and diagnosis[J]. Neurol Neuroimmunol Neuroinflamm 7(3):e682","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4473_CR7","doi-asserted-by":"publisher","first-page":"1441033","DOI":"10.3389\/fneur.2024.1441033","volume":"15","author":"MA Abu","year":"2024","unstructured":"Abu MA, Aldress AS, Alamri F et al (2024) Prognostic factors and treatment outcomes in pediatric autoimmune encephalitis: a multicenter study[J]. Front Neurol 15:1441033","journal-title":"Front Neurol"},{"issue":"1","key":"4473_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14728222.2021.1856370","volume":"25","author":"J Sell","year":"2021","unstructured":"Sell J, Haselmann H, Hallermann S et al (2021) Autoimmune encephalitis: novel therapeutic targets at the preclinical level[J]. Expert Opin Ther Targets 25(1):37\u201347","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"4473_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12883-024-03724-x","volume":"24","author":"J Zhang","year":"2024","unstructured":"Zhang J, Li Y, Liu L et al (2024) Development of a short-term prognostic model for anti-N-methyl-D-aspartate receptor encephalitis in Chinese patients[J]. BMC Neurol 24(1):276","journal-title":"BMC Neurol"},{"key":"4473_CR10","doi-asserted-by":"publisher","first-page":"1457758","DOI":"10.3389\/fimmu.2025.1457758","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Wu J, Wu S et al (2025) Towards an optimal diagnostic and prognostic model based on semi-quantitative assessment of 18F\u2009\u2013\u2009FDG PET in children with autoimmune encephalitis[J]. Front Immunol 16:1457758","journal-title":"Front Immunol"},{"key":"4473_CR11","doi-asserted-by":"publisher","first-page":"612569","DOI":"10.3389\/fneur.2021.612569","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ren G, Ren J et al (2021) A validated nomogram that predicts prognosis of autoimmune encephalitis: a multicenter study in China[J]. Front Neurol 12:612569","journal-title":"Front Neurol"},{"key":"4473_CR12","doi-asserted-by":"publisher","first-page":"765839","DOI":"10.3389\/fimmu.2022.765839","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Qiao S, Li H et al (2022) Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders[J]. Front Immunol 13:765839","journal-title":"Front Immunol"},{"key":"4473_CR13","doi-asserted-by":"publisher","first-page":"1527057","DOI":"10.3389\/fimmu.2025.1527057","volume":"16","author":"J Cheng","year":"2025","unstructured":"Cheng J, Wang Z, Wang J et al (2025) The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study[J]. Front Immunol 16:1527057","journal-title":"Front Immunol"},{"issue":"4","key":"4473_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol 15(4):391\u2013404","journal-title":"Lancet Neurol"},{"key":"4473_CR15","doi-asserted-by":"crossref","unstructured":"Cellucci T, Van Mater H, Graus F et al (2020) Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient[J]. Neurol Neuroimmunol Neuroinflamm 7(2):e663.","DOI":"10.1212\/NXI.0000000000000663"},{"key":"4473_CR16","doi-asserted-by":"publisher","first-page":"11529","DOI":"10.2147\/JIR.S481729","volume":"17","author":"Q Lai","year":"2024","unstructured":"Lai Q, Chen Y, Wang W et al (2024) Identifying Key Prognostic Indicators for Relapse and Chronic Epilepsy in Autoimmune Encephalitis: Insights from a Multicenter Retrospective Study[J]. J Inflamm Res 17:11529\u201311543","journal-title":"J Inflamm Res"},{"issue":"7","key":"4473_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S et al (2021) Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management[J]. J Neurol Neurosurg Psychiatry 92(7):757\u2013768","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"22","key":"4473_CR18","doi-asserted-by":"publisher","first-page":"e2300","DOI":"10.1212\/WNL.0000000000207746","volume":"101","author":"JH Yang","year":"2023","unstructured":"Yang JH, Liu EN, Nguyen L et al (2023) Survival Analysis of Immunotherapy Effects on Relapse Rate in Pediatric and Adult Autoimmune Encephalitis[J]. Neurology 101(22):e2300\u2013e2313","journal-title":"Neurology"},{"issue":"5","key":"4473_CR19","doi-asserted-by":"publisher","first-page":"104444","DOI":"10.1016\/j.braindev.2025.104444","volume":"47","author":"C Hou","year":"2025","unstructured":"Hou C, Zeng Y, Wu W et al (2025) Relapse in pediatric anti-N-methyl-d-aspartate receptor encephalitis: A cohort study in one of the national children\u2019s medical center in China[J]. Brain Dev 47(5):104444","journal-title":"Brain Dev"},{"issue":"4","key":"4473_CR20","doi-asserted-by":"publisher","first-page":"e200421","DOI":"10.1212\/NXI.0000000000200421","volume":"12","author":"NL Ciano-Petersen","year":"2025","unstructured":"Ciano-Petersen NL, Villagr\u00e1n-Garc\u00eda M, Mu\u00f1iz-Castrillo S et al (2025) Relapses in Anti-NMDAR Encephalitis: Clinical Characterization and Predictive Features[J]. Neurol Neuroimmunol Neuroinflamm 12(4):e200421","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"4473_CR21","doi-asserted-by":"publisher","first-page":"e1052","DOI":"10.1212\/NXI.0000000000001052","volume":"8","author":"M Nosadini","year":"2021","unstructured":"Nosadini M, Thomas T, Eyre M et al (2021) International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis[J]. Neurol Neuroimmunol Neuroinflamm 8(5):e1052","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"4473_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pedhc.2015.09.004","volume":"30","author":"S Scheer","year":"2016","unstructured":"Scheer S, John RM, Anti (2016) -N-Methyl-D-Aspartate Receptor Encephalitis in Children and Adolescents[J]. J Pediatr Health Care 30(4):347\u2013358","journal-title":"J Pediatr Health Care"},{"key":"4473_CR23","doi-asserted-by":"publisher","first-page":"605042","DOI":"10.3389\/fped.2021.605042","volume":"9","author":"S Yang","year":"2021","unstructured":"Yang S, Yang L, Liao H et al (2021) Clinical Characteristics and Prognostic Factors of Children With Anti-N-Methyl-D-Aspartate Receptor Encephalitis[J]. Front Pediatr 9:605042","journal-title":"Front Pediatr"},{"key":"4473_CR24","doi-asserted-by":"publisher","first-page":"577899","DOI":"10.1016\/j.jneuroim.2022.577899","volume":"369","author":"Y Yao","year":"2022","unstructured":"Yao Y, Zhang O, Gu L et al (2022) Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis[J]. J Neuroimmunol 369:577899","journal-title":"J Neuroimmunol"},{"issue":"8","key":"4473_CR25","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco J, Irani SR et al (2021) Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management[J]. J Neurol Neurosurg Psychiatry 92(8):897\u2013907","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"4473_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/WCO.0000000000000443","volume":"30","author":"RC Dale","year":"2017","unstructured":"Dale RC, Gorman MP, Lim M (2017) Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges[J]. Curr Opin Neurol 30(3):334\u2013344","journal-title":"Curr Opin Neurol"},{"key":"4473_CR27","doi-asserted-by":"publisher","first-page":"104697","DOI":"10.1016\/j.msard.2023.104697","volume":"74","author":"Q Wu","year":"2023","unstructured":"Wu Q, Xie Q, Liu L et al (2023) Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis[J]. Mult Scler Relat Disord 74:104697","journal-title":"Mult Scler Relat Disord"},{"key":"4473_CR28","doi-asserted-by":"publisher","first-page":"918396","DOI":"10.3389\/fimmu.2022.918396","volume":"13","author":"R Zhong","year":"2022","unstructured":"Zhong R, Chen Q, Zhang X et al (2022) Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study[J]. Front Immunol 13:918396","journal-title":"Front Immunol"},{"issue":"2","key":"4473_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J]. Lancet Neurol 12(2):157\u2013165","journal-title":"Lancet Neurol"},{"issue":"10","key":"4473_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/jnnp-2024-335400","volume":"96","author":"X Gong","year":"2025","unstructured":"Gong X, Liu Y, Ma Y et al (2025) Long-term maintenance of mycophenolate mofetil in anti-NMDA receptor encephalitis (LEARN): a multicentre, open-label, blinded-endpoint, randomised controlled trial[J]. J Neurol Neurosurg Psychiatry 96(10):998\u20131007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"4473_CR31","doi-asserted-by":"publisher","first-page":"e200395","DOI":"10.1212\/NXI.0000000000200395","volume":"12","author":"N Seery","year":"2025","unstructured":"Seery N, Wesselingh R, Beech P et al (2025) Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study[J]. Neurol Neuroimmunol Neuroinflamm 12(4):e200395","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"4473_CR32","doi-asserted-by":"publisher","first-page":"e41747","DOI":"10.1016\/j.heliyon.2025.e41747","volume":"11","author":"LM Zhang","year":"2025","unstructured":"Zhang LM, Xing XL, Zhang BR et al (2025) Efficacy of rituximab as second-line therapy for autoimmune encephalitis: A systematic review and meta-analysis[J]. Heliyon 11(2):e41747","journal-title":"Heliyon"},{"issue":"3","key":"4473_CR33","doi-asserted-by":"publisher","first-page":"e200235","DOI":"10.1212\/NXI.0000000000200235","volume":"11","author":"LW Chen","year":"2024","unstructured":"Chen LW, Oliv\u00e9-Cirera G, Fonseca EG et al (2024) Very Long-Term Functional Outcomes and Dependency in Children With Anti-NMDA Receptor Encephalitis[J]. Neurol Neuroimmunol Neuroinflamm 11(3):e200235","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4473_CR34","doi-asserted-by":"publisher","first-page":"11529","DOI":"10.2147\/JIR.S481729","volume":"17","author":"Q Lai","year":"2024","unstructured":"Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors[J]. Stat Med 15(4):361\u2013387","journal-title":"J Inflamm Res"},{"issue":"9","key":"4473_CR35","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/dmcn.14267","volume":"61","author":"M Nosadini","year":"2019","unstructured":"Nosadini M, Granata T, Matricardi S et al (2019) Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis[J]. Dev Med Child Neurol 61(9):1101\u20131107","journal-title":"Dev Med Child Neurol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-026-04473-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-026-04473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:02:08Z","timestamp":1783454528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-026-04473-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":35,"alternative-id":["4473"],"URL":"https:\/\/doi.org\/10.1007\/s11845-026-04473-1","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was obtained from the Hangzhou Children\u2019s Hospital. This study was performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval"}},{"value":"Informed consent was obtained from all individual participants or their legal guardians included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}